ABBV
Abbvie Inc
Price:  
220.81 
USD
Volume:  
5,256,120.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Abbvie Relative Valuation

-80.9%
Upside

As of 2025-09-17, the Relative Valuation of Abbvie Inc (ABBV) is 42.25 USD. This relative valuation is based on P/E multiples. With the latest stock price at 220.81 USD, the upside of Abbvie Inc based on Relative Valuation is -80.9%.

The range of the Relative Valuation is 36.68 - 51.84 USD.

Range Selected
Trailing P/E multiples 17.2x - 23.3x 18.2x
Forward P/E multiples 16.8x - 22.1x 19.5x
Fair Price 36.68 - 51.84 42.25
Upside -83.4% - -76.5% -80.9%
220.81 USD
Stock Price
42.25 USD
Fair Price

Abbvie Relative Valuation - Historical P/E Data

Date P/E
2025-09-16 101.52
2025-09-15 102.16
2025-09-12 102.50
2025-09-11 103.38
2025-09-10 99.36
2025-09-09 98.78
2025-09-08 98.49
2025-09-05 99.79
2025-09-04 99.99
2025-09-03 99.46
2025-09-02 99.49
2025-08-29 98.77
2025-08-28 97.61
2025-08-27 97.67
2025-08-26 97.82
2025-08-25 97.44
2025-08-22 98.87
2025-08-21 98.35
2025-08-20 98.19
2025-08-19 96.80
2025-08-18 96.98
2025-08-15 97.03
2025-08-14 96.09
2025-08-13 94.58
2025-08-12 93.25
2025-08-11 93.25
2025-08-08 92.98
2025-08-07 93.36
2025-08-06 92.15
2025-08-05 93.21
2025-08-04 92.57
2025-08-01 91.65
2025-07-31 88.74
2025-07-30 88.87
2025-07-29 89.77
2025-07-28 88.50
2025-07-25 89.33
2025-07-24 89.59
2025-07-23 89.45
2025-07-22 87.84
2025-07-21 86.78
2025-07-18 88.85
2025-07-17 89.85
2025-07-16 89.47
2025-07-15 87.50
2025-07-14 89.91
2025-07-11 90.35
2025-07-10 91.54
2025-07-09 89.49
2025-07-08 89.09